Elliptic Laboratories ASA (OSL:ELABS)
Norway · Delayed Price · Currency is NOK 3.200
-0.100 (-3.03%)
Oct 2, 2026, 4:25 PM CET
Elliptic Laboratories ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 404 | 715 | 1,103 | 1,786 | 2,295 | 2,882 | |
Market Cap Growth | -58.53% | -35.20% | -38.24% | -22.15% | -20.36% | 138.61% |
Enterprise Value | 358 | 673 | 1,057 | 1,694 | 2,108 | 2,692 |
Last Close Price | 3.20 | 6.79 | 10.48 | 17.04 | 22.05 | 27.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 123.13 | - | - | - |
Forward PE | - | 16.98 | 12.59 | 40.33 | 40.09 | - |
PS Ratio | 5.06 | 7.06 | 8.36 | 26.15 | 44.08 | 52.78 |
PB Ratio | 1.91 | 3.80 | 3.39 | 5.85 | 7.05 | 8.41 |
P/TBV Ratio | 2.85 | 6.13 | 4.26 | 7.15 | 8.25 | 9.41 |
P/FCF Ratio | - | 119.89 | - | - | - | - |
P/OCF Ratio | - | 119.27 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.49 | 6.65 | 8.01 | 24.80 | 40.48 | 49.30 |
EV/EBITDA Ratio | - | - | 147.34 | - | - | - |
EV/EBIT Ratio | - | - | 224.49 | - | - | - |
EV/FCF Ratio | - | 112.91 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.07 | 0.06 | 0.09 | 0.04 | 0.05 |
Debt / EBITDA Ratio | - | - | 1.56 | - | - | - |
Debt / FCF Ratio | - | 2.20 | - | - | - | - |
Net Debt / Equity Ratio | -0.22 | -0.16 | -0.17 | -0.29 | -0.51 | -0.59 |
Net Debt / EBITDA Ratio | 0.72 | 0.66 | -7.95 | 1.82 | 3.98 | 18.67 |
Net Debt / FCF Ratio | 2.01 | -5.02 | 5.38 | 2.32 | 9.55 | 18.57 |
Asset Turnover | 0.28 | 0.35 | 0.37 | 0.20 | 0.14 | 0.19 |
Quick Ratio | 8.77 | 5.16 | 7.77 | 7.32 | 13.06 | 14.67 |
Current Ratio | 8.77 | 5.21 | 7.83 | 7.45 | 13.13 | 14.67 |
Return on Equity (ROE) | -59.32% | -54.53% | 2.84% | -12.08% | -9.87% | -4.23% |
Return on Assets (ROA) | -14.44% | -10.13% | 0.83% | -8.94% | -7.31% | -2.36% |
Return on Invested Capital (ROIC) | -40.42% | -22.16% | 1.02% | -26.55% | -27.91% | -8.79% |
Return on Capital Employed (ROCE) | -30.30% | -24.10% | 1.40% | -15.40% | -12.70% | -3.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -37.94% | -19.58% | 0.81% | -2.13% | -1.44% | -0.39% |
FCF Yield | -5.66% | 0.83% | -0.96% | -2.16% | -0.76% | -0.38% |
Buyback Yield / Dilution | -12.16% | 5.38% | -6.67% | -0.33% | -5.74% | -10.18% |